184 related articles for article (PubMed ID: 6721988)
1. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
[TBL] [Abstract][Full Text] [Related]
2. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
Rostin M; Barthe P; Houin G; Alvinerie M; Bouissou F
Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
[TBL] [Abstract][Full Text] [Related]
4. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
[TBL] [Abstract][Full Text] [Related]
5. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
Milsap RL; George DE; Szefler SJ; Murray KA; Lebenthal E; Jusko WJ
Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
Powell LW; Axelsen E
Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
[TBL] [Abstract][Full Text] [Related]
7. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
Rose JQ; Yurchak AM; Jusko WJ
J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid pharmacokinetics in liver disease.
Uribe M; Go VL
Clin Pharmacokinet; 1979; 4(3):233-40. PubMed ID: 383357
[TBL] [Abstract][Full Text] [Related]
9. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
Schalm SW; Summerskill WH; Go VL
Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
Unadkat JD; Rowland M
Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
[TBL] [Abstract][Full Text] [Related]
11. Monitoring prednisone and prednisolone.
Jusko WJ; Rose JQ
Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
Green OC; Winter RJ; Kawahara FS; Phillips LS; Lewy PR; Hart RL; Pachman LM
J Pediatr; 1978 Aug; 93(2):299-303. PubMed ID: 671172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
Frey BM; Schaad HJ; Frey FJ
Eur J Clin Pharmacol; 1984; 26(4):505-11. PubMed ID: 6734709
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
[TBL] [Abstract][Full Text] [Related]
15. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
Colburn WA; Sibley CR; Buller RH
J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
[TBL] [Abstract][Full Text] [Related]
16. Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin.
Unadkat JD; Rowland M
J Pharm Pharmacol; 1984 Sep; 36(9):582-5. PubMed ID: 6149280
[TBL] [Abstract][Full Text] [Related]
17. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
Ferry JJ; Wagner JG
Biopharm Drug Dispos; 1987; 8(3):261-72. PubMed ID: 3593903
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission.
Faure C; André J; Pelatan C; Munck A; Giraud M; Cèzard JP; Jacqz-Aigrain E
Eur J Clin Pharmacol; 1998 Sep; 54(7):555-60. PubMed ID: 9832298
[TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.
Tanner AR; Caffin JA; Halliday JW; Powell LW
Br J Clin Pharmacol; 1979 Apr; 7(4):397-400. PubMed ID: 444359
[TBL] [Abstract][Full Text] [Related]
20. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
